Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03590509 · ClinicalTrials.gov registry record · NA

An Integrated Telemedicine-Home Visitation Program to Increase Outcomes for Children With Medical Complexity

A NA study of Chronic Disease, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
422
Enrollment target
1
Study location

NCT03590509: Completed NA study of Chronic Disease, sponsored by The University of Texas Health Science Center, Houston.

NCT03590509 is a NA study of Chronic Disease that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 422 participants, below the 89,934-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03590509, a NA study of Chronic Disease, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
422 participants
Enrollment target
1
Study location

Study Summary

Children with medical complexity (CMC) account for \<1% of all children but approximately 40% of all pediatric deaths and inpatient care spending in the U.S.1 Optimizing their outcomes requires a comprehensive approach to augmenting care in all settings: clinic, hospital, and home. The clinic component of the comprehensive care (CC) program provides 24/7 access to an experienced team of primary care providers and subspecialists and reduced their serious illnesses and hospital and ICU days by 47-69% and health-system costs by \>$10,000 per child-year.2,3 The hospital component (inpatient consultation service) is further improving outcomes. Having improved both inpatient and outpatient care, the investigators now propose to complete a 360 degree approach by developing and rigorously assessing an integrated telemedicine-home-visitation program (THVP) to augment care for CMC in their homes to reduce the need for clinic visits as well hospitalizations. Building on prior experience in using telemedicine for children at UTH and evidence of benefits in other populations, 4,5 the providers will use a convenient, inexpensive, HIPAA-compliant telemedicine platform to make observations in the home to augment care, help address acute problems remotely at any hour, better coordinate care with healthcare personnel, and thereby reduce clinic visits, ED visits, and hospitalizations. Home visits will be conducted by a nurse home visitor whenever considered likely to be beneficial for any of the CMC and at least once by the primary care providers (PCPs) immediately following enrollment of children with chronic respiratory failure requiring mechanical ventilation at home. To promote reimbursements and further grant funding, the investigators will test the integrated THVP in a randomized quality improvement (QI) pilot study to verify its effectiveness in reducing total days of care outside the home.

Primary Outcome

Days of care in the hospital, ER, or clinic \[excluding well-child checks\]

Conditions Studied

Interventions

  • OTHER Telemedicine Program
  • OTHER Usual Comprehensive Care

Study Locations (1)

Texas

  • The University of Texas Health Science, Houston - Houston

Trial Details

FieldValue
Enrollment Target 422 participants
Start Date 2018-08-23
Est. Completion 2020-05-05
Phase NA

What the finished NCT03590509 record still lists

NCT03590509 is an interventional study that assigns participants to a tested intervention. The registered 422 participants enrollment target is mid-sized for trials with a published cap, below the 89,934-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Chronic Disease appearing as the primary indexed condition, and to 2 interventions - of which Telemedicine Program is the first listed.

NCT03590509 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03590509 about?

NCT03590509 is a clinical study titled "An Integrated Telemedicine-Home Visitation Program to Increase Outcomes for Children With Medical Complexity". Children with medical complexity (CMC) account for \<1% of all children but approximately 40% of all pediatric deaths and inpatient care spending in the U.S.1 Optimizing their outcomes requires a comprehensive approach to augmenting care in all settings: clinic, hospital, and home. The clinic compon...

What is the current status of trial NCT03590509?

This trial is currently completed. It is a NA study. The enrollment target is 422 participants. The study started on 2018-08-23. Estimated completion is 2020-05-05.

What conditions does trial NCT03590509 study?

This clinical trial studies the following conditions: Chronic Disease.

What interventions are being tested in trial NCT03590509?

The interventions under investigation include: Telemedicine Program (OTHER), Usual Comprehensive Care (OTHER).

Who is sponsoring clinical trial NCT03590509?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03590509 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03590509's enrollment target sits among peer trials

422 18th of 48 higher than 31 of 48 other Chronic Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04763356 · 422 participants · NA

    Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

  • NCT06837246 · 422 participants · NA

    A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population

  • NCT07298967 · 422 participants · NA

    ORCHARDS-AIR Study

  • NCT06935591 · 423 participants · NA

    Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03590509, the US trial registry maintained by the National Library of Medicine. NCT03590509 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.